Part:BBa_K4359006
ClyA-Myc-Affi
Introduction
ClyA-Myc-Affi is the composite part derived from assembling Cytolysin A (BBa_K4359000), (SSSSG)x2 serine glycine linker (BBa_K4359003), myc-tag (BBa_K82303) and anti-HER2 affibody (BBa_K4359002). It is used to target the human epidermal growth factor receptor 2 (HER2) protein.
Biology
Cytolysin A acts as a localization signal and targets the protein to the bacterial outer membrane. Subsequently, outer membrane vesicles (OMVs) derived from the outer membrane carry ClyA-Myc-Affi. The serine-glycine linker is flexible and joins ClyA with the C terminus domains. The myc epitope tag was added to enable antibody-based detection in Western blots and immunofluorescence. The anti-HER2 affibody is an affinity protein against HER2. Detailed information on each basic part can be found on their corresponding pages.
This protein is designed to be displayed on the surface of OMVs, and target them to breast cancer cells over expressing HER2. ClyA contains disulphide bonds and requires strains with periplasmic disulphide bond reduction machinery, such as dsba.
Usage
ClyA-Myc-Affi was cloned into pGEX-4T1, between the EcoN1 and BamH1 sites. pGEX-4T1 is compatible for expression in K12 strains which lack a genomic copy of the T7 RNA polymerase (and hence cannot use other expresion vectors such as pET). The expression of ClyA-Myc-Affi was under the control of the IPTG-inducible tac operon. We tested expression with 1mM of IPTG.
OMVs were isolated from E.coli cultures expressing ClyA-Myc-Affi. ClyA-Myc-Affi correctly localizes to the OMV fraction, as noted from the following SDS PAGE gel.
Anti-myc western blots were used to detect ClyA-Myc-Affi in cell pellets and OMVs.
//chassis/prokaryote/ecoli
None |